FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 33 filers reported holding FORTE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,727 | -52.7% | 29,800 | -25.7% | 0.00% | – |
| Q2 2023 | $41,709 | +116.6% | 40,105 | +110.3% | 0.00% | – |
| Q1 2023 | $19,258 | -72.6% | 19,067 | -72.8% | 0.00% | – |
| Q4 2022 | $70,169 | +43.2% | 70,169 | +53.5% | 0.00% | – |
| Q3 2022 | $49,000 | -72.2% | 45,700 | -66.2% | 0.00% | – |
| Q2 2022 | $176,000 | -52.7% | 135,387 | -46.9% | 0.00% | – |
| Q1 2022 | $372,000 | -51.0% | 254,831 | -28.1% | 0.00% | – |
| Q4 2021 | $759,000 | -37.6% | 354,199 | -13.9% | 0.00% | – |
| Q3 2021 | $1,217,000 | +267.7% | 411,147 | +4073.7% | 0.00% | – |
| Q2 2021 | $331,000 | -91.6% | 9,851 | -91.4% | 0.00% | -100.0% |
| Q1 2021 | $3,948,000 | -69.9% | 115,193 | -68.1% | 0.00% | -66.7% |
| Q4 2020 | $13,135,000 | -20.5% | 360,743 | +5.9% | 0.00% | -40.0% |
| Q3 2020 | $16,523,000 | – | 340,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 84,989 | $3,094,000 | 1.41% |
| BVF INC/IL | 718,788 | $26,171,000 | 1.03% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $106,926,000 | 0.83% |
| MYDA Advisors LLC | 28,000 | $1,019,000 | 0.30% |
| Maven Securities LTD | 83,374 | $3,036,000 | 0.30% |
| Parkman Healthcare Partners LLC | 31,098 | $1,132,000 | 0.29% |
| Woodline Partners LP | 192,266 | $7,000,000 | 0.19% |
| Sepio Capital, LP | 58,591 | $2,133,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 325,000 | $11,833,000 | 0.17% |
| Perceptive Advisors | 350,000 | $12,744,000 | 0.14% |